These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3337899)

  • 1. Natural history of idiopathic refractory sideroblastic anemia.
    Cazzola M; Barosi G; Gobbi PG; Invernizzi R; Riccardi A; Ascari E
    Blood; 1988 Feb; 71(2):305-12. PubMed ID: 3337899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
    Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
    Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature.
    Kushner JP; Lee GR; Wintrobe MM; Cartwright GE
    Medicine (Baltimore); 1971 May; 50(3):139-59. PubMed ID: 5286053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired idiopathic sideroblastic anemia (author's transl)].
    Sigaux F; Richard MF; Imbert M; Sultan C
    Pathol Biol (Paris); 1979 Sep; 27(7):421-32. PubMed ID: 388322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired idiopathic sideroblastic anemia. Apropos of 39 cases].
    Fenaux P; Estienne MH; Laï JL; Beuscart R; Dupriez B; Jouet JP; Bauters F
    Rev Med Interne; 1989; 10(4):323-9. PubMed ID: 2799116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
    Cazzola M; Malcovati L
    Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
    Sarycheva TG; Tsvetaeva NV; Kozinets GI
    Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory myelodysplastic anaemias with hypocellular bone marrow.
    Yoshida Y; Oguma S; Uchino H; Maekawa T
    J Clin Pathol; 1988 Jul; 41(7):763-7. PubMed ID: 3410972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin in refractory anemias.
    Solomon LR; Hillman RS; Finch CA
    Acta Haematol; 1981; 66(1):1-5. PubMed ID: 6794292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.
    Cheng DS; Kushner JP; Wintrobe MM
    Cancer; 1979 Aug; 44(2):724-31. PubMed ID: 383260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic and hematologic follow-up studies in idiopathic refractory sideroblastic anemia (IRSA) (author's transl)].
    Mende S; Weissenfels I; Pribilla W
    Blut; 1980 Nov; 41(5):367-76. PubMed ID: 7437531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ring sideroblasts].
    Brattås MKL; Reikvam H
    Tidsskr Nor Laegeforen; 2017 Nov; 137(21):. PubMed ID: 29135187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired idiopathic sideroblastic anemia (author's transl)].
    Sigaux F; Ricard MF; Imbert M; Sultan C
    Sem Hop; 1980 Mar 18-25; 56(11-12):583-94. PubMed ID: 6245466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
    Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
    Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
    Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
    Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does rapidly progressive iron overload in a young girl with sideroblastic anemia also signify the presence of hereditary hemochromatosis?
    Scimeca PG; Weinblatt ME; Kahn E; Kochen JA
    Pediatr Hematol Oncol; 1994; 11(1):99-104. PubMed ID: 8155505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological classification of acquired bone marrow failure based on quantitative assessment of erythroid function.
    Cazzola M; Bergamaschi G; Huebers HA; Finch CA
    Eur J Haematol; 1987 May; 38(5):426-32. PubMed ID: 3653364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.